Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
piroxicam — COX-2 Interaction
Drug-target interaction between piroxicam and COX-2. Synthetic organic pharmacological agent targeting this protein.
pitolisant — H3 receptor Interaction
Drug-target interaction between pitolisant and H3 receptor. Synthetic organic pharmacological agent targeting this protein.
plerixafor — CXCR4 Interaction
Drug-target interaction between plerixafor and CXCR4. Synthetic organic pharmacological agent targeting this protein.
polatuzumab vedotin — CD79B Interaction
Drug-target interaction between polatuzumab vedotin and CD79B. Antibody pharmacological agent targeting this protein.
ponatinib — ABL proto-oncogene 1, non-receptor tyrosine kinase Interaction
Drug-target interaction between ponatinib and ABL proto-oncogene 1, non-receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
ponesimod — S1P1 receptor Interaction
Drug-target interaction between ponesimod and S1P1 receptor. Synthetic organic pharmacological agent targeting this protein.
ponesimod — S1P5 receptor Interaction
Drug-target interaction between ponesimod and S1P5 receptor. Synthetic organic pharmacological agent targeting this protein.
practolol — β1-adrenoceptor Interaction
Drug-target interaction between practolol and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
pralatrexate — dihydrofolate reductase Interaction
Drug-target interaction between pralatrexate and dihydrofolate reductase. Synthetic organic pharmacological agent targeting this protein.
pralidoxime — acetylcholinesterase (Yt blood group) Interaction
Drug-target interaction between pralidoxime and acetylcholinesterase (Yt blood group). Synthetic organic pharmacological agent targeting this protein.
pralsetinib — ret proto-oncogene Interaction
Drug-target interaction between pralsetinib and ret proto-oncogene. Synthetic organic pharmacological agent targeting this protein.
pramipexole — D2 receptor Interaction
Drug-target interaction between pramipexole and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
pramipexole — D3 receptor Interaction
Drug-target interaction between pramipexole and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
pranlukast — CysLT1 receptor Interaction
Drug-target interaction between pranlukast and CysLT1 receptor. Synthetic organic pharmacological agent targeting this protein.
pravastatin — hydroxymethylglutaryl-CoA reductase Interaction
Drug-target interaction between pravastatin and hydroxymethylglutaryl-CoA reductase. Synthetic organic pharmacological agent targeting this protein.
prazosin — α1A-adrenoceptor Interaction
Drug-target interaction between prazosin and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
prazosin — α1B-adrenoceptor Interaction
Drug-target interaction between prazosin and α1B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
prazosin — α1D-adrenoceptor Interaction
Drug-target interaction between prazosin and α1D-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
prednisolone — Glucocorticoid receptor Interaction
Drug-target interaction between prednisolone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
prednisone — Glucocorticoid receptor Interaction
Drug-target interaction between prednisone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
probenecid — Organic anion transporter 1 Interaction
Drug-target interaction between probenecid and Organic anion transporter 1. Synthetic organic pharmacological agent targeting this protein.
probucol — ABCA1 Interaction
Drug-target interaction between probucol and ABCA1. Synthetic organic pharmacological agent targeting this protein.
procaterol — β2-adrenoceptor Interaction
Drug-target interaction between procaterol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
prochlorperazine — D2 receptor Interaction
Drug-target interaction between prochlorperazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
prochlorperazine — D3 receptor Interaction
Drug-target interaction between prochlorperazine and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
progesterone — Progesterone receptor Interaction
Drug-target interaction between progesterone and Progesterone receptor. Metabolite pharmacological agent targeting this protein.
promazine — D2 receptor Interaction
Drug-target interaction between promazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
promazine — D3 receptor Interaction
Drug-target interaction between promazine and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
promethazine — H1 receptor Interaction
Drug-target interaction between promethazine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
propafenone — β1-adrenoceptor Interaction
Drug-target interaction between propafenone and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
propantheline — M1 receptor Interaction
Drug-target interaction between propantheline and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
propantheline — M2 receptor Interaction
Drug-target interaction between propantheline and M2 receptor. Synthetic organic pharmacological agent targeting this protein.
propantheline — M3 receptor Interaction
Drug-target interaction between propantheline and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
propranolol — β2-adrenoceptor Interaction
Drug-target interaction between propranolol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
propranolol — β3-adrenoceptor Interaction
Drug-target interaction between propranolol and β3-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
propylthiouracil — thyroid peroxidase Interaction
Drug-target interaction between propylthiouracil and thyroid peroxidase. Synthetic organic pharmacological agent targeting this protein.
protriptyline — NET Interaction
Drug-target interaction between protriptyline and NET. Synthetic organic pharmacological agent targeting this protein.
protriptyline — SERT Interaction
Drug-target interaction between protriptyline and SERT. Synthetic organic pharmacological agent targeting this protein.
pucolentimab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between pucolentimab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
quetiapine — 5-HT2A receptor Interaction
Drug-target interaction between quetiapine and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
quetiapine — D2 receptor Interaction
Drug-target interaction between quetiapine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
quinaprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between quinaprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
quizartinib — fms related receptor tyrosine kinase 3 Interaction
Drug-target interaction between quizartinib and fms related receptor tyrosine kinase 3. Synthetic organic pharmacological agent targeting this protein.
raloxifene — Estrogen receptor-α Interaction
Drug-target interaction between raloxifene and Estrogen receptor-α. Synthetic organic pharmacological agent targeting this protein.
raloxifene — Estrogen receptor-β Interaction
Drug-target interaction between raloxifene and Estrogen receptor-β. Synthetic organic pharmacological agent targeting this protein.
raltitrexed — thymidylate synthetase Interaction
Drug-target interaction between raltitrexed and thymidylate synthetase. Synthetic organic pharmacological agent targeting this protein.
ramelteon — MT1 receptor Interaction
Drug-target interaction between ramelteon and MT1 receptor. Synthetic organic pharmacological agent targeting this protein.
ramelteon — MT2 receptor Interaction
Drug-target interaction between ramelteon and MT2 receptor. Synthetic organic pharmacological agent targeting this protein.
ramipril — Angiotensin-converting enzyme Interaction
Drug-target interaction between ramipril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
ramiprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between ramiprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
ramucirumab — kinase insert domain receptor Interaction
Drug-target interaction between ramucirumab and kinase insert domain receptor. Antibody pharmacological agent targeting this protein.
ranitidine — H2 receptor Interaction
Drug-target interaction between ranitidine and H2 receptor. Synthetic organic pharmacological agent targeting this protein.
rasagiline — Monoamine oxidase B Interaction
Drug-target interaction between rasagiline and Monoamine oxidase B. Synthetic organic pharmacological agent targeting this protein.
reboxetine — NET Interaction
Drug-target interaction between reboxetine and NET. Synthetic organic pharmacological agent targeting this protein.
recaticimab — proprotein convertase subtilisin/kexin type 9 Interaction
Drug-target interaction between recaticimab and proprotein convertase subtilisin/kexin type 9. Antibody pharmacological agent targeting this protein.
regadenoson — A2A receptor Interaction
Drug-target interaction between regadenoson and A2A receptor. Synthetic organic pharmacological agent targeting this protein.
regorafenib — B-Raf proto-oncogene, serine/threonine kinase Interaction
Drug-target interaction between regorafenib and B-Raf proto-oncogene, serine/threonine kinase. Synthetic organic pharmacological agent targeting this protein.
relatlimab — LAG3 (CD223) Interaction
Drug-target interaction between relatlimab and LAG3 (CD223). Antibody pharmacological agent targeting this protein.
repaglinide — ATP-binding cassette, sub-family C (CFTR/MRP), member 8 Interaction
Drug-target interaction between repaglinide and ATP-binding cassette, sub-family C (CFTR/MRP), member 8. Synthetic organic pharmacological agent targeting this protein.
reserpine — Vesicular monoamine transporter 2 Interaction
Drug-target interaction between reserpine and Vesicular monoamine transporter 2. Synthetic organic pharmacological agent targeting this protein.